Healthcare Services Group, Inc. (HCSG) 10-Year Financial Performance & Capital Metrics

HCSG •

HealthcareHealthcare FacilitiesHealthcare staffing and facility services

AboutHealthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary. The Housekeeping segment engages in the cleaning, disinfecting, and sanitizing of resident rooms and common areas of the client's facility, as well as laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at a client's facility. The Dietary segment provides food purchasing, meal preparation, and professional dietitian services, which include the development of menus that meet the dietary needs of residents. This segment also offers on-site management and clinical consulting services to facilities. As of December 31, 2021, the company provided its services to approximately 3,000 facilities. Healthcare Services Group, Inc. was incorporated in 1976 and is based in Bensalem, Pennsylvania.Show more

Revenue $1.84B +7.1%
EBITDA $65M -3.7%
Net Income $59M +49.6%
EPS (Diluted) 0.81 +52.8%
Gross Margin 13.03% -2.0%
EBITDA Margin 3.56% -10.1%
Operating Margin 2.64% -14.9%
Net Margin 3.21% +39.7%
ROE 10.6% +28.5%
ROIC 7.75% -14.9%
Debt/Equity 0.03 -4.3%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9
✓20 consecutive years of dividend growth
✓Momentum leader: RS Rating 80 (top 20%)
✓High quality earnings: Operating CF exceeds net income
✓Efficient asset utilization: 2.3x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.49%

5Y0.86%

3Y2.82%

TTM6.26%

Profit (Net Income) CAGR

10Y0.18%

5Y-9.76%

3Y19.92%

TTM-20.77%

EPS CAGR

10Y0.12%

5Y-9.31%

3Y20.76%

TTM-21.57%

ROCE

10Y Avg14.97%

5Y Avg8.89%

3Y Avg8.77%

Latest7.79%

Peer Comparison

Healthcare staffing and facility services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CCELCryo-Cell International, Inc.	27.15M	3.37	67.40	2.05%	1.26%		13.29%
HCSGHealthcare Services Group, Inc.	1.67B	21.77	26.88	7.08%	2.2%	8.01%	8.32%	0.03
SOLVSolventum Corporation	12.87B	74.20	8.36	0.86%	18.69%	30.82%		1.00
AMSAmerican Shared Hospital Services	13.74M	2.11	6.39	32.9%	-7.65%	-7.87%		0.77
SYRASyra Health Corp. Class A Common Stock	60K	0.10	-0.19	44.73%	-16.89%	-57.31%		0.16
AMNAMN Healthcare Services, Inc.	987.48M	19.48	-5.06	-21.26%	-3.5%	-14.9%	24.26%	1.55
CCRNCross Country Healthcare, Inc.	280.81M	8.70	-19.77	-33.46%	-1.39%	-3.84%	39.67%	0.01

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	1.56B	1.87B	2.01B	1.84B	1.76B	1.64B	1.69B	1.67B	1.72B	1.84B
Revenue Growth %	8.76%	19.42%	7.65%	-8.37%	-4.37%	-6.72%	2.94%	-1.11%	2.65%	7.08%
Cost of Goods Sold+	1.34B	1.61B	1.77B	1.61B	1.49B	1.41B	1.5B	1.46B	1.49B	1.6B
COGS % of Revenue	85.72%	86.41%	88.21%	87.62%	84.78%	85.96%	88.56%	87.15%	86.71%	86.97%
Gross Profit+	223.17M	253.62M	236.84M	227.9M	267.99M	230.57M	193.31M	214.75M	228.09M	239.41M
Gross Margin %	14.28%	13.59%	11.79%	12.38%	15.22%	14.04%	11.44%	12.85%	13.29%	13.03%
Gross Profit Growth %	11.17%	13.64%	-6.62%	-3.77%	17.59%	-13.96%	-16.16%	11.09%	6.21%	4.96%
Operating Expenses+	105.42M	126.73M	136.6M	150.02M	267.99M	166.43M	149.52M	160.09M	174.82M	190.87M
OpEx % of Revenue	6.75%	6.79%	6.8%	8.15%	15.22%	10.14%	8.85%	9.58%	10.19%	10.39%
Selling, General & Admin	105.42M	126.73M	136.6M	150.02M	141.58M	166.43M	149.52M	160.09M	174.82M	190.87M
SG&A % of Revenue	6.75%	6.79%	6.8%	8.15%	8.04%	10.14%	8.85%	9.58%	10.19%	10.39%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	126.41M	0	0	0	0	0
Operating Income+	117.75M	126.89M	100.24M	77.88M	0	64.13M	43.79M	54.66M	53.27M	48.54M
Operating Margin %	7.54%	6.8%	4.99%	4.23%	-	3.91%	2.59%	3.27%	3.1%	2.64%
Operating Income Growth %	32.23%	7.76%	-21%	-22.31%	-100%	-	-31.72%	24.82%	-2.54%	-8.88%
EBITDA+	125.25M	135.78M	109.51M	91.82M	144.83M	78.8M	59.1M	69M	67.86M	65.32M
EBITDA Margin %	8.02%	7.28%	5.45%	4.99%	8.23%	4.8%	3.5%	4.13%	3.96%	3.56%
EBITDA Growth %	29.51%	8.4%	-19.35%	-16.15%	57.73%	-45.59%	-24.99%	16.74%	-1.66%	-3.74%
D&A (Non-Cash Add-back)	7.5M	8.89M	9.27M	13.94M	14.27M	14.67M	15.32M	14.34M	14.59M	16.78M
EBIT	119.25M	134.33M	103M	88.56M	130.56M	66.9M	47.54M	60.91M	59.38M	48.54M
Net Interest Income+	0	-1.36M	-3.09M	-3.46M	-1.37M	-1.39M	-2.99M	-7.86M	-6.44M	0
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	1.36M	3.09M	3.46M	1.37M	1.39M	2.99M	7.86M	6.44M	0
Other Income/Expense	2.63M	6.08M	2.07M	7.22M	129.19M	1.38M	764K	-1.6M	-330K	19.33M
Pretax Income+	120.39M	132.97M	99.91M	85.1M	129.19M	65.51M	44.55M	53.06M	52.94M	67.87M
Pretax Margin %	7.7%	7.13%	4.97%	4.62%	7.34%	3.99%	2.64%	3.17%	3.09%	3.69%
Income Tax+	42.99M	44.74M	16.39M	20.52M	30.5M	16.97M	10.31M	14.67M	13.47M	8.81M
Effective Tax Rate %	64.29%	66.35%	83.6%	75.89%	76.39%	74.1%	76.86%	72.35%	74.56%	87.02%
Net Income+	77.4M	88.23M	83.52M	64.58M	98.68M	48.54M	34.24M	38.39M	39.47M	59.06M
Net Margin %	4.95%	4.73%	4.16%	3.51%	5.61%	2.96%	2.03%	2.3%	2.3%	3.21%
Net Income Growth %	33.39%	13.99%	-5.33%	-22.68%	52.8%	-50.81%	-29.46%	12.1%	2.83%	49.63%
Net Income (Continuing)	77.4M	88.23M	83.52M	64.58M	98.68M	48.54M	34.24M	38.39M	39.47M	59.06M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.05	1.19	1.12	0.87	1.32	0.65	0.46	0.52	0.53	0.81
EPS Growth %	31.25%	13.33%	-5.88%	-22.32%	51.72%	-50.76%	-29.23%	13.04%	1.92%	52.83%
EPS (Basic)	1.06	1.20	1.13	0.87	1.32	0.65	0.46	0.52	0.54	0.82
Diluted Shares Outstanding	73.47M	74.35M	74.61M	74.59M	74.78M	74.96M	74.35M	74.34M	73.99M	73.03M
Basic Shares Outstanding	72.75M	73.36M	74M	74.36M	74.7M	74.82M	74.34M	74.29M	73.75M	72.38M
Dividend Payout Ratio	68.92%	62.62%	68.48%	91.28%	61.52%	128.19%	185.07%	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	414.62M	527.41M	508.14M	515.73M	572.4M	546.38M	508.63M	571.7M	556.65M	576.41M
Cash & Short-Term Investments	91.58M	82.78M	102.39M	118.04M	264.34M	185.19M	121.48M	147.46M	135.77M	167.96M
Cash Only	23.85M	9.56M	26.02M	27.33M	139.33M	70.79M	26.28M	54.33M	85.24M	125.19M
Short-Term Investments	67.73M	73.22M	76.36M	90.71M	125.01M	114.4M	95.2M	93.13M	50.53M	42.77M
Accounts Receivable	271.28M	378.72M	341.84M	340.93M	255.47M	302.2M	336.78M	383.51M	382.34M	312.55M
Days Sales Outstanding	63.36	74.07	62.11	67.6	52.97	67.18	72.73	83.75	81.34	62.09
Inventory	37.8M	42.39M	41.44M	36.52M	31.59M	26.02M	21.16M	18.48M	16.75M	16.8M
Days Inventory Outstanding	10.3	9.6	8.54	8.26	7.73	6.73	5.16	4.63	4.11	3.84
Other Current Assets	0	0	22.47M	20.25M	21M	0	29.21M	22.25M	21.8M	79.11M
Total Non-Current Assets+	113.82M	148.6M	184.47M	214.98M	221.04M	240.42M	209.7M	231.49M	258.82M	217.84M
Property, Plant & Equipment	13.46M	13.51M	12.9M	28.82M	26.56M	28.1M	22.98M	28.77M	28.2M	27.59M
Fixed Asset Turnover	116.14x	138.14x	155.72x	63.87x	66.27x	58.43x	73.57x	58.09x	60.84x	66.60x
Goodwill	44.44M	51.08M	51.08M	51.08M	51.08M	74.75M	75.53M	75.53M	75.53M	79.8M
Intangible Assets	14.41M	30.88M	26.52M	22.35M	18.19M	20.8M	15.95M	12.13M	9.44M	6.96M
Long-Term Investments	21.83M	36.86M	51.6M	46.99M	34.42M	29.26M	32.61M	24.83M	41.05M	25.21M
Other Non-Current Assets	9.87M	8.76M	21.81M	37.25M	46.82M	46.69M	34.3M	42.47M	53.73M	59.81M
Total Assets+	528.45M	676M	692.6M	730.71M	793.45M	786.8M	718.33M	803.18M	815.47M	794.25M
Asset Turnover	2.96x	2.76x	2.90x	2.52x	2.22x	2.09x	2.35x	2.08x	2.10x	2.31x
Asset Growth %	9.88%	27.92%	2.46%	5.5%	8.59%	-0.84%	-8.7%	11.81%	1.53%	-2.6%
Total Current Liabilities+	100.87M	184.17M	163.39M	148.65M	162.26M	191.13M	178.62M	216.93M	192.55M	170.38M
Accounts Payable	42.91M	74.46M	61.47M	54.42M	52.24M	64.42M	68.3M	83.22M	81.15M	77.38M
Days Payables Outstanding	11.69	16.86	12.66	12.31	12.78	16.66	16.65	20.85	19.91	17.68
Short-Term Debt	0	35.38M	30M	15.18M	5.3M	6.5M	25M	25M	8.4M	0
Deferred Revenue (Current)	0	-87.6M	7.14M	0	0	0	0	0	0	0
Other Current Liabilities	27.97M	26.81M	29.59M	34.57M	34.11M	44.55M	41M	0	41.53M	170.38M
Current Ratio	4.11x	2.86x	3.11x	3.47x	3.53x	2.86x	2.85x	2.64x	2.89x	3.38x
Quick Ratio	3.74x	2.63x	2.86x	3.22x	3.33x	2.72x	2.73x	2.55x	2.80x	3.28x
Cash Conversion Cycle	61.97	66.82	57.99	63.55	47.92	57.25	61.24	67.53	65.54	48.25
Total Non-Current Liabilities+	88.73M	91.88M	88.43M	121.75M	150.73M	143M	113.54M	129.64M	123M	113.67M
Long-Term Debt	0	0	0	0	0	0	0	0	0	9.66M
Capital Lease Obligations	0	0	0	11.65M	11.36M	11.3M	8.1M	11.23M	8.03M	9.66M
Deferred Tax Liabilities	9.98M	7.27M	7.2M	8.12M	8.42M	9.27M	7.07M	12.53M	12.7M	0
Other Non-Current Liabilities	88.73M	91.88M	88.43M	101.99M	130.95M	122.43M	105.45M	105.87M	102.27M	94.35M
Total Liabilities	189.6M	276.05M	251.82M	270.4M	312.99M	334.12M	292.16M	346.57M	315.55M	180.03M
Total Debt+	0	35.38M	30M	26.83M	16.66M	17.8M	33.1M	43.63M	16.43M	19.32M
Net Debt	-23.85M	25.82M	3.98M	-501K	-122.67M	-52.99M	6.82M	-10.7M	-68.8M	-115.53M
Debt / Equity	-	0.09x	0.07x	0.06x	0.03x	0.04x	0.08x	0.10x	0.03x	0.03x
Debt / EBITDA	-	0.26x	0.27x	0.29x	0.12x	0.23x	0.56x	0.63x	0.24x	0.30x
Net Debt / EBITDA	-0.19x	0.19x	0.04x	-0.01x	-0.85x	-0.67x	0.12x	-0.15x	-1.01x	-1.77x
Interest Coverage	-	93.10x	32.40x	22.51x	-	46.31x	14.66x	6.96x	8.27x	-
Total Equity+	338.84M	399.95M	440.78M	460.31M	480.46M	452.68M	426.17M	456.62M	499.93M	614.22M
Equity Growth %	14.3%	18.04%	10.21%	4.43%	4.38%	-5.78%	-5.86%	7.14%	9.49%	22.86%
Book Value per Share	4.61	5.38	5.91	6.17	6.42	6.04	5.73	6.14	6.76	8.41
Total Shareholders' Equity	338.84M	399.95M	440.78M	460.31M	480.46M	452.68M	426.17M	456.62M	499.93M	510.21M
Common Stock	742K	750K	753K	756K	758K	760K	762K	763K	765K	768K
Retained Earnings	130.94M	163.86M	190.09M	195.46M	200.89M	183.96M	154.5M	185.01M	224.56M	283.67M
Treasury Stock	-10.19M	-9.86M	-9.66M	-9.44M	-8.96M	-30.16M	-27.91M	-37.75M	-41.44M	0
Accumulated OCI	-319K	837K	158K	2.92M	5.56M	4M	-3.48M	-1.84M	-2.32M	-448K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	41.4M	7.63M	80.03M	93.58M	217.21M	37.11M	-8.17M	43.5M	30.8M	144.97M
Operating CF Margin %	2.65%	0.41%	3.98%	5.08%	12.34%	2.26%	-0.48%	2.6%	1.8%	7.89%
Operating CF Growth %	-34.66%	-81.57%	948.9%	16.93%	132.11%	-82.92%	-122.01%	632.61%	-29.19%	370.64%
Net Income	77.4M	88.23M	83.52M	64.58M	98.68M	45.86M	34.63M	38.39M	39.47M	59.06M
Depreciation & Amortization	7.5M	8.89M	9.27M	13.94M	14.27M	14.67M	15.32M	14.34M	14.59M	17.07M
Stock-Based Compensation	4.25M	276K	5.9M	6.87M	7.87M	8.83M	9.21M	8.98M	9.16M	12.01M
Deferred Taxes	20K	1.89M	-13.01M	-684K	-5.89M	3.07M	5.05M	-4.82M	-2.94M	19.2M
Other Non-Cash Items	4.89M	3.04M	54.19M	19.66M	3.4M	7.83M	42.4M	30.77M	40.72M	37.63M
Working Capital Changes	-52.66M	-94.68M	-59.84M	-10.78M	98.88M	-43.15M	-114.77M	-44.16M	-70.19M	0
Change in Receivables	-61.05M	-121.64M	-44.36M	-29.53M	38.08M	-37.19M	-78.71M	-74.56M	-61.81M	0
Change in Inventory	-1.49M	-1.87M	950K	4.76M	4.93M	5.6M	4.85M	2.69M	1.73M	-48K
Change in Payables	-4.25M	11.2M	-9.14M	-9.53M	-7.25M	10.24M	-13.75M	7.43M	-9.74M	-12.06M
Cash from Investing+	-6.45M	-14.97M	-9.59M	-16.46M	-36.84M	-22.99M	2.58M	-3.29M	6.05M	-11M
Capital Expenditures	-5.44M	-5.4M	-4.94M	-4.37M	-4.34M	-5.69M	-5.21M	-5.41M	-6.34M	-5.82M
CapEx % of Revenue	0.35%	0.29%	0.25%	0.24%	0.25%	0.35%	0.31%	0.32%	0.37%	0.32%
Acquisitions	275K	-4.58M	640K	199K	0	-23.88M	-114K	0	-2.75M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	275K	338K	640K	0	274K	211K	393K	121K	211K	-9.67M
Cash from Financing+	-44.28M	-6.96M	-53.98M	-75.82M	-68.37M	-82.65M	-38.93M	-12.15M	-31.05M	-63.33M
Debt Issued (Net)	0	35.38M	-5.38M	-20M	-10M	0	25M	0	-25M	0
Equity Issued (Net)	109K	95K	89K	1000K	93K	-1000K	106K	-1000K	-1000K	0
Dividends Paid	-53.34M	-55.24M	-57.2M	-58.95M	-60.7M	-62.23M	-63.37M	0	0	0
Share Repurchases	0	0	0	0	0	-21.54M	0	-11.28M	-5.02M	-61.59M
Other Financing	8.95M	12.81M	8.52M	-587K	2.25M	1.01M	-661K	-871K	-1.03M	-63.33M
Net Change in Cash	-9.34M	-14.3M	16.47M	1.3M	112M	-68.54M	-44.52M	28.05M	5.8M	70.64M
Free Cash Flow+	35.96M	2.23M	75.09M	89.21M	212.87M	31.42M	-13.38M	38.09M	24.47M	139.15M
FCF Margin %	2.3%	0.12%	3.74%	4.85%	12.09%	1.91%	-0.79%	2.28%	1.43%	7.57%
FCF Growth %	-38.39%	-93.79%	3262.79%	18.81%	138.61%	-85.24%	-142.57%	384.76%	-35.77%	468.75%
FCF per Share	0.49	0.03	1.01	1.20	2.85	0.42	-0.18	0.51	0.33	1.91
FCF Conversion (FCF/Net Income)	0.53x	0.09x	0.96x	1.45x	2.20x	0.76x	-0.24x	1.13x	0.78x	2.45x
Interest Paid	574K	1.36M	3.09M	3.46M	1.37M	1.39M	2.82M	7.81M	6.49M	0
Taxes Paid	32.53M	35.37M	37.68M	20.03M	44.87M	21.23M	3.31M	5.58M	15.23M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	24.37%	23.88%	19.87%	14.33%	20.98%	10.4%	7.79%	8.7%	8.25%	10.6%
Return on Invested Capital (ROIC)	30.55%	25.69%	17.27%	12.91%	-	12.7%	7.89%	9.33%	9.11%	7.75%
Gross Margin	14.28%	13.59%	11.79%	12.38%	15.22%	14.04%	11.44%	12.85%	13.29%	13.03%
Net Margin	4.95%	4.73%	4.16%	3.51%	5.61%	2.96%	2.03%	2.3%	2.3%	3.21%
Debt / Equity	-	0.09x	0.07x	0.06x	0.03x	0.04x	0.08x	0.10x	0.03x	0.03x
Interest Coverage	-	93.10x	32.40x	22.51x	-	46.31x	14.66x	6.96x	8.27x	-
FCF Conversion	0.53x	0.09x	0.96x	1.45x	2.20x	0.76x	-0.24x	1.13x	0.78x	2.45x
Revenue Growth	8.76%	19.42%	7.65%	-8.37%	-4.37%	-6.72%	2.94%	-1.11%	2.65%	7.08%

US Stock Screener

...

Healthcare Services Group, Inc. (HCSG) 10-Year Financial Performance & Capital Metrics

HCSG •

HealthcareHealthcare FacilitiesHealthcare staffing and facility services

Revenue $1.84B +7.1%
EBITDA $65M -3.7%
Net Income $59M +49.6%
EPS (Diluted) 0.81 +52.8%
Gross Margin 13.03% -2.0%
EBITDA Margin 3.56% -10.1%
Operating Margin 2.64% -14.9%
Net Margin 3.21% +39.7%
ROE 10.6% +28.5%
ROIC 7.75% -14.9%
Debt/Equity 0.03 -4.3%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Strong Piotroski F-Score: 7/9
✓20 consecutive years of dividend growth
✓Momentum leader: RS Rating 80 (top 20%)
✓High quality earnings: Operating CF exceeds net income
✓Efficient asset utilization: 2.3x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.49%

5Y0.86%

3Y2.82%

TTM6.26%

Profit (Net Income) CAGR

10Y0.18%

5Y-9.76%

3Y19.92%

TTM-20.77%

EPS CAGR

10Y0.12%

5Y-9.31%

3Y20.76%

TTM-21.57%

ROCE

10Y Avg14.97%

5Y Avg8.89%

3Y Avg8.77%

Latest7.79%

Peer Comparison

Healthcare staffing and facility services

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
CCELCryo-Cell International, Inc.	27.15M	3.37	67.40	2.05%	1.26%		13.29%
HCSGHealthcare Services Group, Inc.	1.67B	21.77	26.88	7.08%	2.2%	8.01%	8.32%	0.03
SOLVSolventum Corporation	12.87B	74.20	8.36	0.86%	18.69%	30.82%		1.00
AMSAmerican Shared Hospital Services	13.74M	2.11	6.39	32.9%	-7.65%	-7.87%		0.77
SYRASyra Health Corp. Class A Common Stock	60K	0.10	-0.19	44.73%	-16.89%	-57.31%		0.16
AMNAMN Healthcare Services, Inc.	987.48M	19.48	-5.06	-21.26%	-3.5%	-14.9%	24.26%	1.55
CCRNCross Country Healthcare, Inc.	280.81M	8.70	-19.77	-33.46%	-1.39%	-3.84%	39.67%	0.01

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	1.56B	1.87B	2.01B	1.84B	1.76B	1.64B	1.69B	1.67B	1.72B	1.84B
Revenue Growth %	8.76%	19.42%	7.65%	-8.37%	-4.37%	-6.72%	2.94%	-1.11%	2.65%	7.08%
Cost of Goods Sold+	1.34B	1.61B	1.77B	1.61B	1.49B	1.41B	1.5B	1.46B	1.49B	1.6B
COGS % of Revenue	85.72%	86.41%	88.21%	87.62%	84.78%	85.96%	88.56%	87.15%	86.71%	86.97%
Gross Profit+	223.17M	253.62M	236.84M	227.9M	267.99M	230.57M	193.31M	214.75M	228.09M	239.41M
Gross Margin %	14.28%	13.59%	11.79%	12.38%	15.22%	14.04%	11.44%	12.85%	13.29%	13.03%
Gross Profit Growth %	11.17%	13.64%	-6.62%	-3.77%	17.59%	-13.96%	-16.16%	11.09%	6.21%	4.96%
Operating Expenses+	105.42M	126.73M	136.6M	150.02M	267.99M	166.43M	149.52M	160.09M	174.82M	190.87M
OpEx % of Revenue	6.75%	6.79%	6.8%	8.15%	15.22%	10.14%	8.85%	9.58%	10.19%	10.39%
Selling, General & Admin	105.42M	126.73M	136.6M	150.02M	141.58M	166.43M	149.52M	160.09M	174.82M	190.87M
SG&A % of Revenue	6.75%	6.79%	6.8%	8.15%	8.04%	10.14%	8.85%	9.58%	10.19%	10.39%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	126.41M	0	0	0	0	0
Operating Income+	117.75M	126.89M	100.24M	77.88M	0	64.13M	43.79M	54.66M	53.27M	48.54M
Operating Margin %	7.54%	6.8%	4.99%	4.23%	-	3.91%	2.59%	3.27%	3.1%	2.64%
Operating Income Growth %	32.23%	7.76%	-21%	-22.31%	-100%	-	-31.72%	24.82%	-2.54%	-8.88%
EBITDA+	125.25M	135.78M	109.51M	91.82M	144.83M	78.8M	59.1M	69M	67.86M	65.32M
EBITDA Margin %	8.02%	7.28%	5.45%	4.99%	8.23%	4.8%	3.5%	4.13%	3.96%	3.56%
EBITDA Growth %	29.51%	8.4%	-19.35%	-16.15%	57.73%	-45.59%	-24.99%	16.74%	-1.66%	-3.74%
D&A (Non-Cash Add-back)	7.5M	8.89M	9.27M	13.94M	14.27M	14.67M	15.32M	14.34M	14.59M	16.78M
EBIT	119.25M	134.33M	103M	88.56M	130.56M	66.9M	47.54M	60.91M	59.38M	48.54M
Net Interest Income+	0	-1.36M	-3.09M	-3.46M	-1.37M	-1.39M	-2.99M	-7.86M	-6.44M	0
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	1.36M	3.09M	3.46M	1.37M	1.39M	2.99M	7.86M	6.44M	0
Other Income/Expense	2.63M	6.08M	2.07M	7.22M	129.19M	1.38M	764K	-1.6M	-330K	19.33M
Pretax Income+	120.39M	132.97M	99.91M	85.1M	129.19M	65.51M	44.55M	53.06M	52.94M	67.87M
Pretax Margin %	7.7%	7.13%	4.97%	4.62%	7.34%	3.99%	2.64%	3.17%	3.09%	3.69%
Income Tax+	42.99M	44.74M	16.39M	20.52M	30.5M	16.97M	10.31M	14.67M	13.47M	8.81M
Effective Tax Rate %	64.29%	66.35%	83.6%	75.89%	76.39%	74.1%	76.86%	72.35%	74.56%	87.02%
Net Income+	77.4M	88.23M	83.52M	64.58M	98.68M	48.54M	34.24M	38.39M	39.47M	59.06M
Net Margin %	4.95%	4.73%	4.16%	3.51%	5.61%	2.96%	2.03%	2.3%	2.3%	3.21%
Net Income Growth %	33.39%	13.99%	-5.33%	-22.68%	52.8%	-50.81%	-29.46%	12.1%	2.83%	49.63%
Net Income (Continuing)	77.4M	88.23M	83.52M	64.58M	98.68M	48.54M	34.24M	38.39M	39.47M	59.06M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	1.05	1.19	1.12	0.87	1.32	0.65	0.46	0.52	0.53	0.81
EPS Growth %	31.25%	13.33%	-5.88%	-22.32%	51.72%	-50.76%	-29.23%	13.04%	1.92%	52.83%
EPS (Basic)	1.06	1.20	1.13	0.87	1.32	0.65	0.46	0.52	0.54	0.82
Diluted Shares Outstanding	73.47M	74.35M	74.61M	74.59M	74.78M	74.96M	74.35M	74.34M	73.99M	73.03M
Basic Shares Outstanding	72.75M	73.36M	74M	74.36M	74.7M	74.82M	74.34M	74.29M	73.75M	72.38M
Dividend Payout Ratio	68.92%	62.62%	68.48%	91.28%	61.52%	128.19%	185.07%	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	414.62M	527.41M	508.14M	515.73M	572.4M	546.38M	508.63M	571.7M	556.65M	576.41M
Cash & Short-Term Investments	91.58M	82.78M	102.39M	118.04M	264.34M	185.19M	121.48M	147.46M	135.77M	167.96M
Cash Only	23.85M	9.56M	26.02M	27.33M	139.33M	70.79M	26.28M	54.33M	85.24M	125.19M
Short-Term Investments	67.73M	73.22M	76.36M	90.71M	125.01M	114.4M	95.2M	93.13M	50.53M	42.77M
Accounts Receivable	271.28M	378.72M	341.84M	340.93M	255.47M	302.2M	336.78M	383.51M	382.34M	312.55M
Days Sales Outstanding	63.36	74.07	62.11	67.6	52.97	67.18	72.73	83.75	81.34	62.09
Inventory	37.8M	42.39M	41.44M	36.52M	31.59M	26.02M	21.16M	18.48M	16.75M	16.8M
Days Inventory Outstanding	10.3	9.6	8.54	8.26	7.73	6.73	5.16	4.63	4.11	3.84
Other Current Assets	0	0	22.47M	20.25M	21M	0	29.21M	22.25M	21.8M	79.11M
Total Non-Current Assets+	113.82M	148.6M	184.47M	214.98M	221.04M	240.42M	209.7M	231.49M	258.82M	217.84M
Property, Plant & Equipment	13.46M	13.51M	12.9M	28.82M	26.56M	28.1M	22.98M	28.77M	28.2M	27.59M
Fixed Asset Turnover	116.14x	138.14x	155.72x	63.87x	66.27x	58.43x	73.57x	58.09x	60.84x	66.60x
Goodwill	44.44M	51.08M	51.08M	51.08M	51.08M	74.75M	75.53M	75.53M	75.53M	79.8M
Intangible Assets	14.41M	30.88M	26.52M	22.35M	18.19M	20.8M	15.95M	12.13M	9.44M	6.96M
Long-Term Investments	21.83M	36.86M	51.6M	46.99M	34.42M	29.26M	32.61M	24.83M	41.05M	25.21M
Other Non-Current Assets	9.87M	8.76M	21.81M	37.25M	46.82M	46.69M	34.3M	42.47M	53.73M	59.81M
Total Assets+	528.45M	676M	692.6M	730.71M	793.45M	786.8M	718.33M	803.18M	815.47M	794.25M
Asset Turnover	2.96x	2.76x	2.90x	2.52x	2.22x	2.09x	2.35x	2.08x	2.10x	2.31x
Asset Growth %	9.88%	27.92%	2.46%	5.5%	8.59%	-0.84%	-8.7%	11.81%	1.53%	-2.6%
Total Current Liabilities+	100.87M	184.17M	163.39M	148.65M	162.26M	191.13M	178.62M	216.93M	192.55M	170.38M
Accounts Payable	42.91M	74.46M	61.47M	54.42M	52.24M	64.42M	68.3M	83.22M	81.15M	77.38M
Days Payables Outstanding	11.69	16.86	12.66	12.31	12.78	16.66	16.65	20.85	19.91	17.68
Short-Term Debt	0	35.38M	30M	15.18M	5.3M	6.5M	25M	25M	8.4M	0
Deferred Revenue (Current)	0	-87.6M	7.14M	0	0	0	0	0	0	0
Other Current Liabilities	27.97M	26.81M	29.59M	34.57M	34.11M	44.55M	41M	0	41.53M	170.38M
Current Ratio	4.11x	2.86x	3.11x	3.47x	3.53x	2.86x	2.85x	2.64x	2.89x	3.38x
Quick Ratio	3.74x	2.63x	2.86x	3.22x	3.33x	2.72x	2.73x	2.55x	2.80x	3.28x
Cash Conversion Cycle	61.97	66.82	57.99	63.55	47.92	57.25	61.24	67.53	65.54	48.25
Total Non-Current Liabilities+	88.73M	91.88M	88.43M	121.75M	150.73M	143M	113.54M	129.64M	123M	113.67M
Long-Term Debt	0	0	0	0	0	0	0	0	0	9.66M
Capital Lease Obligations	0	0	0	11.65M	11.36M	11.3M	8.1M	11.23M	8.03M	9.66M
Deferred Tax Liabilities	9.98M	7.27M	7.2M	8.12M	8.42M	9.27M	7.07M	12.53M	12.7M	0
Other Non-Current Liabilities	88.73M	91.88M	88.43M	101.99M	130.95M	122.43M	105.45M	105.87M	102.27M	94.35M
Total Liabilities	189.6M	276.05M	251.82M	270.4M	312.99M	334.12M	292.16M	346.57M	315.55M	180.03M
Total Debt+	0	35.38M	30M	26.83M	16.66M	17.8M	33.1M	43.63M	16.43M	19.32M
Net Debt	-23.85M	25.82M	3.98M	-501K	-122.67M	-52.99M	6.82M	-10.7M	-68.8M	-115.53M
Debt / Equity	-	0.09x	0.07x	0.06x	0.03x	0.04x	0.08x	0.10x	0.03x	0.03x
Debt / EBITDA	-	0.26x	0.27x	0.29x	0.12x	0.23x	0.56x	0.63x	0.24x	0.30x
Net Debt / EBITDA	-0.19x	0.19x	0.04x	-0.01x	-0.85x	-0.67x	0.12x	-0.15x	-1.01x	-1.77x
Interest Coverage	-	93.10x	32.40x	22.51x	-	46.31x	14.66x	6.96x	8.27x	-
Total Equity+	338.84M	399.95M	440.78M	460.31M	480.46M	452.68M	426.17M	456.62M	499.93M	614.22M
Equity Growth %	14.3%	18.04%	10.21%	4.43%	4.38%	-5.78%	-5.86%	7.14%	9.49%	22.86%
Book Value per Share	4.61	5.38	5.91	6.17	6.42	6.04	5.73	6.14	6.76	8.41
Total Shareholders' Equity	338.84M	399.95M	440.78M	460.31M	480.46M	452.68M	426.17M	456.62M	499.93M	510.21M
Common Stock	742K	750K	753K	756K	758K	760K	762K	763K	765K	768K
Retained Earnings	130.94M	163.86M	190.09M	195.46M	200.89M	183.96M	154.5M	185.01M	224.56M	283.67M
Treasury Stock	-10.19M	-9.86M	-9.66M	-9.44M	-8.96M	-30.16M	-27.91M	-37.75M	-41.44M	0
Accumulated OCI	-319K	837K	158K	2.92M	5.56M	4M	-3.48M	-1.84M	-2.32M	-448K
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	41.4M	7.63M	80.03M	93.58M	217.21M	37.11M	-8.17M	43.5M	30.8M	144.97M
Operating CF Margin %	2.65%	0.41%	3.98%	5.08%	12.34%	2.26%	-0.48%	2.6%	1.8%	7.89%
Operating CF Growth %	-34.66%	-81.57%	948.9%	16.93%	132.11%	-82.92%	-122.01%	632.61%	-29.19%	370.64%
Net Income	77.4M	88.23M	83.52M	64.58M	98.68M	45.86M	34.63M	38.39M	39.47M	59.06M
Depreciation & Amortization	7.5M	8.89M	9.27M	13.94M	14.27M	14.67M	15.32M	14.34M	14.59M	17.07M
Stock-Based Compensation	4.25M	276K	5.9M	6.87M	7.87M	8.83M	9.21M	8.98M	9.16M	12.01M
Deferred Taxes	20K	1.89M	-13.01M	-684K	-5.89M	3.07M	5.05M	-4.82M	-2.94M	19.2M
Other Non-Cash Items	4.89M	3.04M	54.19M	19.66M	3.4M	7.83M	42.4M	30.77M	40.72M	37.63M
Working Capital Changes	-52.66M	-94.68M	-59.84M	-10.78M	98.88M	-43.15M	-114.77M	-44.16M	-70.19M	0
Change in Receivables	-61.05M	-121.64M	-44.36M	-29.53M	38.08M	-37.19M	-78.71M	-74.56M	-61.81M	0
Change in Inventory	-1.49M	-1.87M	950K	4.76M	4.93M	5.6M	4.85M	2.69M	1.73M	-48K
Change in Payables	-4.25M	11.2M	-9.14M	-9.53M	-7.25M	10.24M	-13.75M	7.43M	-9.74M	-12.06M
Cash from Investing+	-6.45M	-14.97M	-9.59M	-16.46M	-36.84M	-22.99M	2.58M	-3.29M	6.05M	-11M
Capital Expenditures	-5.44M	-5.4M	-4.94M	-4.37M	-4.34M	-5.69M	-5.21M	-5.41M	-6.34M	-5.82M
CapEx % of Revenue	0.35%	0.29%	0.25%	0.24%	0.25%	0.35%	0.31%	0.32%	0.37%	0.32%
Acquisitions	275K	-4.58M	640K	199K	0	-23.88M	-114K	0	-2.75M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	275K	338K	640K	0	274K	211K	393K	121K	211K	-9.67M
Cash from Financing+	-44.28M	-6.96M	-53.98M	-75.82M	-68.37M	-82.65M	-38.93M	-12.15M	-31.05M	-63.33M
Debt Issued (Net)	0	35.38M	-5.38M	-20M	-10M	0	25M	0	-25M	0
Equity Issued (Net)	109K	95K	89K	1000K	93K	-1000K	106K	-1000K	-1000K	0
Dividends Paid	-53.34M	-55.24M	-57.2M	-58.95M	-60.7M	-62.23M	-63.37M	0	0	0
Share Repurchases	0	0	0	0	0	-21.54M	0	-11.28M	-5.02M	-61.59M
Other Financing	8.95M	12.81M	8.52M	-587K	2.25M	1.01M	-661K	-871K	-1.03M	-63.33M
Net Change in Cash	-9.34M	-14.3M	16.47M	1.3M	112M	-68.54M	-44.52M	28.05M	5.8M	70.64M
Free Cash Flow+	35.96M	2.23M	75.09M	89.21M	212.87M	31.42M	-13.38M	38.09M	24.47M	139.15M
FCF Margin %	2.3%	0.12%	3.74%	4.85%	12.09%	1.91%	-0.79%	2.28%	1.43%	7.57%
FCF Growth %	-38.39%	-93.79%	3262.79%	18.81%	138.61%	-85.24%	-142.57%	384.76%	-35.77%	468.75%
FCF per Share	0.49	0.03	1.01	1.20	2.85	0.42	-0.18	0.51	0.33	1.91
FCF Conversion (FCF/Net Income)	0.53x	0.09x	0.96x	1.45x	2.20x	0.76x	-0.24x	1.13x	0.78x	2.45x
Interest Paid	574K	1.36M	3.09M	3.46M	1.37M	1.39M	2.82M	7.81M	6.49M	0
Taxes Paid	32.53M	35.37M	37.68M	20.03M	44.87M	21.23M	3.31M	5.58M	15.23M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	24.37%	23.88%	19.87%	14.33%	20.98%	10.4%	7.79%	8.7%	8.25%	10.6%
Return on Invested Capital (ROIC)	30.55%	25.69%	17.27%	12.91%	-	12.7%	7.89%	9.33%	9.11%	7.75%
Gross Margin	14.28%	13.59%	11.79%	12.38%	15.22%	14.04%	11.44%	12.85%	13.29%	13.03%
Net Margin	4.95%	4.73%	4.16%	3.51%	5.61%	2.96%	2.03%	2.3%	2.3%	3.21%
Debt / Equity	-	0.09x	0.07x	0.06x	0.03x	0.04x	0.08x	0.10x	0.03x	0.03x
Interest Coverage	-	93.10x	32.40x	22.51x	-	46.31x	14.66x	6.96x	8.27x	-
FCF Conversion	0.53x	0.09x	0.96x	1.45x	2.20x	0.76x	-0.24x	1.13x	0.78x	2.45x
Revenue Growth	8.76%	19.42%	7.65%	-8.37%	-4.37%	-6.72%	2.94%	-1.11%	2.65%	7.08%

Healthcare Services Group, Inc. (HCSG) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare HCSG vs Peers

vs SOLV

vs AMN

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Healthcare Services Group, Inc. (HCSG) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare HCSG vs Peers

vs SOLV

vs AMN

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios